A novel model of injured liver ductal organoids to investigate cholangiocyte apoptosis with relevance to biliary atresia
- PMID: 33084932
- DOI: 10.1007/s00383-020-04765-2
A novel model of injured liver ductal organoids to investigate cholangiocyte apoptosis with relevance to biliary atresia
Abstract
Purpose: The fibrogenic process in cholangiopathic diseases such as biliary atresia (BA) involves bile duct injury and apoptosis of cholangiocytes, which leads to the progression of liver fibrosis into liver cirrhosis and can result in end-staged liver disease. Recent advances in the development of organoids or mini-organ structures have allowed us to create an ex vivo injury model of the bile duct that mimics bile duct injury in BA. The aim of this experimental study was to develop a novel model of injured intrahepatic cholangiocytes as this can be relevant to BA. Our new model is important for studying the pathophysiological response of bile ducts to injury and the role of cholangiocytes in initiating the fibrogenic cascade. In addition, it has the potential to be used as a tool for developing new treatment strategies for BA.
Methods: Liver ductal organoids were generated from the liver of healthy neonatal mouse pups. Intrahepatic bile duct fragments were isolated and cultured in Matrigel dome. Injury was induced in the organoids by administration of acetaminophen in culture medium. The organoids were then evaluated for fibrogenic cytokines expression, cell apoptosis marker and cell proliferation marker.
Results: Organoids generated from intrahepatic bile duct fragments organized themselves into single-layer epithelial spheroids with lumen on the inside mimicking in vivo bile ducts. After 24-h exposure to acetaminophen, cholangiocytes in the organoids responded to the injury by increasing expression of fibrogenic cytokines, transforming growth factor beta-1 (TGF-β1) and platelet-derived growth factor-BB (PDGF-BB). This fibrogenic response of injured organoids was associated with increased cholangiocyte apoptosis and decreased cholangiocyte proliferation.
Conclusion: To our knowledge this is the first description of cholangiocyte injury in the organoids derived from intrahepatic bile ducts. Our injury model demonstrated that cholangiocyte apoptosis and its fibrogenic response may play a role in initiation of the fibrogenic process in cholangiopathic diseases such as BA. These findings are important for the development of novel therapy to reduce cholangiocyte apoptosis and to halt the early fibrogenic cascade in liver fibrogenesis. This novel injury model can prove very valuable for future research in biliary atresia.
Keywords: Bile duct injury; Cell apoptosis; Fibrogenic cytokine; Organoid.
Similar articles
-
Human amniotic fluid stem cells attenuate cholangiocyte apoptosis in a bile duct injury model of liver ductal organoids.J Pediatr Surg. 2021 Jan;56(1):11-16. doi: 10.1016/j.jpedsurg.2020.09.043. Epub 2020 Oct 6. J Pediatr Surg. 2021. PMID: 33129508
-
Beta-amyloid deposition around hepatic bile ducts is a novel pathobiological and diagnostic feature of biliary atresia.J Hepatol. 2020 Dec;73(6):1391-1403. doi: 10.1016/j.jhep.2020.06.012. Epub 2020 Jun 16. J Hepatol. 2020. PMID: 32553668
-
Integrative single-cell and spatial transcriptomic analyses identify a pathogenic cholangiocyte niche and TNFRSF12A as therapeutic target for biliary atresia.Hepatology. 2025 Apr 1;81(4):1146-1163. doi: 10.1097/HEP.0000000000001064. Epub 2024 Aug 23. Hepatology. 2025. PMID: 39178365
-
Biliary Atresia - emerging diagnostic and therapy opportunities.EBioMedicine. 2021 Dec;74:103689. doi: 10.1016/j.ebiom.2021.103689. Epub 2021 Nov 12. EBioMedicine. 2021. PMID: 34781099 Free PMC article. Review.
-
Cholangiocyte organoids for disease, cancer, and regenerative medicine.Eur J Cell Biol. 2025 Mar;104(1):151472. doi: 10.1016/j.ejcb.2024.151472. Epub 2024 Dec 19. Eur J Cell Biol. 2025. PMID: 39721346 Review.
Cited by
-
Autoimmune diseases refractory to corticosteroids and immunosuppressants.Front Immunol. 2024 Sep 16;15:1447337. doi: 10.3389/fimmu.2024.1447337. eCollection 2024. Front Immunol. 2024. PMID: 39351223 Free PMC article. Review.
-
Development of liver inflammatory injury in biliary atresia: from basic to clinical research.Pediatr Surg Int. 2023 May 30;39(1):207. doi: 10.1007/s00383-023-05489-9. Pediatr Surg Int. 2023. PMID: 37249714 Review.
-
Biliary Epithelial Senescence in Liver Disease: There Will Be SASP.Front Mol Biosci. 2021 Dec 21;8:803098. doi: 10.3389/fmolb.2021.803098. eCollection 2021. Front Mol Biosci. 2021. PMID: 34993234 Free PMC article. Review.
-
Serum TGF-β1 and VEGF Levels Reflect the Liver Hardness and Function in Children with Biliary Atresia.Comput Math Methods Med. 2022 Jul 21;2022:5802548. doi: 10.1155/2022/5802548. eCollection 2022. Comput Math Methods Med. 2022. Retraction in: Comput Math Methods Med. 2023 Oct 18;2023:9797525. doi: 10.1155/2023/9797525. PMID: 35912145 Free PMC article. Retracted.
-
Research on biliary atresia and epigenetic factors from the perspective of transcriptomics: identification of key genes and experimental validation.Front Pediatr. 2025 Jul 17;13:1624671. doi: 10.3389/fped.2025.1624671. eCollection 2025. Front Pediatr. 2025. PMID: 40746357 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources